Brain Oxygen Optimization in Severe Traumatic Brain Injury Phase-II: A Phase II Randomized Trial*David O. Okonkwo, Ramon Diaz‐Arrastia, Lori Shutter et al.|Critical Care Medicine|2017Cited by 469
Recovery After Mild Traumatic Brain Injury in Patients Presenting to US Level I Trauma CentersLindsay D. Nelson, Miri Rabinowitz, Nancy Temkin et al.|JAMA Neurology|2019Cited by 439
Functional Outcomes Over the First Year After Moderate to Severe Traumatic Brain Injury in the Prospective, Longitudinal TRACK-TBI StudyMichael McCrea, Laura B. Ngwenya, Joseph T. Giacino et al.|JAMA Neurology|2021Cited by 394
Metabolism of [U‐<sup>13</sup>C]glucose in human brain tumors <i>in vivo</i>Elizabeth A. Maher, Ralph J. DeBerardinis, Isaac Marin‐Valencia et al.|NMR in Biomedicine|2012Cited by 340
Association between plasma GFAP concentrations and MRI abnormalities in patients with CT-negative traumatic brain injury in the TRACK-TBI cohort: a prospective multicentre studyJohn K. Yue, Alastair J. Martin, Esther L. Yuh et al.|The Lancet Neurology|2019Cited by 239